胺对人类NMDA受体的作用的结构基础
Youyi Zhang1,2, Fei Ye3, Tongtong Zhang1,2
1Institute of Neuroscience, State Key Laboratory of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China.
Nature
|July 29, 2021
概括
作为抗抑郁药胺的关键成分,S-胺与N-甲基-D-酸盐 (NMDA) 受体结合. 结构分析揭示了特定的结合部位和相互作用,指导了基于胺的新型抗抑郁药的开发.
科学领域:
- 神经科学
- 结构生物学
- 药理学
背景情况:
- 胺是一种治疗耐药抑郁症的快速作用抗抑郁药.
- 胺作为一种非竞争性的N-甲基-D-酸盐 (NMDA) 受体通道阻断剂.
- S-胺是胺中最有效的抗抑郁剂.
研究的目的:
- 确定与S-胺结合的人类NMDA受体的冷电子显微镜结构.
- 阐明S-胺与NMDA受体相互作用的结构基础.
- 确定参与S-胺结合和活性的关键氨基酸残留物.
主要方法:
- 用冷电子显微镜检测NMDA受体结构.
- 复杂的形成与S-胺,甘氨酸和谷氨酸.
- 模拟分子动力学分析S-胺的运动.
- 定位突变,以评估关键的残留功能.
主要成果:
- 在NMDA受体的中央前庭中发现了S- 胺的结合口袋.
- 观察到S-胺在结合口袋中占据了两个不同的位置.
- 确定了关键的残留物,Leucine 642 (GluN2A/643在GluN2B上) 和阿斯巴拉金616 (GluN1).
- 这些残留物中的突变降低了胺对NMDA受体通道的抑制作用.
结论:
- 关于S-ketamine如何与人类NMDA受体结合并抑制的结构见解.
- 对S-ketamine抗抑郁机制的关键相互作用的鉴定.
- 为设计基于胺的抗抑郁药物治疗提供了基础.
相关概念视频
Parenteral Anesthetics: Overview
350
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
350
Local Anesthetics: Mechanism of Action
2.7K
Local anesthetics (LAs) block sensory and motor impulses by inhibiting the sodium channels on the nerve cell membranes. This induces temporary loss of sensation, relieving pain in a specific body area.
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
2.7K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
3.1K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.1K
Antiepileptic Drugs: Glutamate Antagonists
607
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
607
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
2.3K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
2.3K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
654
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
654


